PCVX vs PTGX Stock Comparison

PTGX currently leads PCVX in this stock comparison, with AIQ scores of 73 vs 66. The clearest difference is quality, while PCVX has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 7 points
PCVX
Healthcare
vs
PTGX
Healthcare
PCVX
Vaxcyte, Inc.
Price
$63.37
Day move
-2.04%
AIQ Score
66/100
Best edge
Momentum
Sector
Healthcare
PTGX
Protagonist Therapeutics, Inc.
Leads
Price
$131
Day move
-2.55%
AIQ Score
73/100
Best edge
Quality
Sector
Healthcare

What is the main difference between PCVX and PTGX?

PTGX leads the current stock comparison as Protagonist Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Vaxcyte, Inc. vs Protagonist Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 5/10

PTGX leads

PTGX leads by 7 AIQ points, primarily on Quality and Risk Resilience. Wall Street currently favors PCVX on target upside.

Competitive: 3 of 5 evidence groups support PTGX, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Stable
PCVX

Vaxcyte, Inc.

AIQ Score
66/100
AIQ Edge Score
10/10
PTGX

Protagonist Therapeutics, Inc.

Leads
AIQ Score
73/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors PTGX over PCVX, 73 versus 66 as of Nov 15, 2026. PTGX's advantage is driven primarily by stronger quality and risk resilience, while PCVX holds the stronger momentum profile. PTGX also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors PCVX. 3 of 5 covered evidence groups favor PTGX today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. PTGX lead: Stable — the AIQ differential has held near 7 points over 30 sessions.

Compare Vaxcyte, Inc. and Protagonist Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

PCVX
+153.4%
PTGX
+259.6%

Price return comparison

Growth of $10,000, price only

PCVX $25,338 · PTGX $35,956

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare PCVX and PTGX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PCVX advantage
0
PTGX advantage
  • Quality54 vs 81
    PTGX +27
  • Risk Resilience53 vs 70
    PTGX +17
  • Momentum81 vs 70
    PCVX +11

3 of 5 evidence groups favor PTGX. PTGX’s edge is concentrated in quality and risk resilience; PCVX keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

PCVX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-18.8%)
  • RSI Midline Rejection — bearish, momentum, short horizon
PTGX-2 AIQ

Largest factor move: Momentum -3

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (1.25x)

PTGX's lead narrowed by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — PCVX and PTGX both carry a full feed there.

The central trade-off

PTGX (Protagonist Therapeutics, Inc.): the stronger current systematic profile, led by quality and risk resilience.

PCVX (Vaxcyte, Inc.): the counter-case, on momentum, technicals, analyst expectations — but at materially higher volatility, 58.3% against 37.7%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PTGX

PTGX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PTGX

PTGX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

PCVX

PCVX on the Momentum factor, by 11 points.

Lower downside

PTGX

PTGX on Risk Resilience, by 17 points.

Analyst upside

PCVX

PCVX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors PTGX, analyst targets favor PCVX. That disagreement is the most useful thing on this page.

MeasurePCVXPTGXNote
Implied upside to target+93%+35%PCVX has more room
Target dispersion+4.1%+17%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1114Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor PTGX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePTGX66 vs 73
FundamentalsPTGXEPS growth -1% vs 34.4%; TTM ROE -11.9% vs 20.3%
ValuationNot coveredNot covered
TechnicalsPCVXPrice vs 50-day 1.8% vs -6.7%; vs 200-day 9.8% vs 9.8%
Risk ResiliencePTGXRisk Resilience 53 vs 70
Analyst expectationsPCVXTarget upside 93% vs 35%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PCVX and PTGX and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 7 points.
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PTGX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

PTGX lead: Stable — the AIQ differential has held near 7 points over 30 sessions.

May 27PCVX leads above the line · PTGX leads belowNov 13
Today
PTGX +7
66 vs 73
7 sessions ago
PTGX +10
66 vs 76
30 sessions ago
PTGX +9
67 vs 76
90 sessions ago
PTGX +19
63 vs 82

The lead changed hands 2 times in this window, most recently on Jun 12 when PCVX moved ahead of PTGX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PCVXConflicted

5 bullish / 2 bearish / 1 neutral, conflicted

Only PCVX

  • Beta Spike Warning — bearish, risk_regime, long horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • RSI Midline Rejection — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
PTGXConflicted

3 bullish / 1 bearish / 1 neutral, conflicted

Only PTGX

  • Accumulation Pattern — bullish, volume, medium horizon (1.25x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Drawdown Recovery Signal.

PTGX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PCVXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.04%, AIQ 0 points).

PTGXConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -2.55%, AIQ -2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PCVX closes the Quality gap — currently 27 points behind, the largest single contributor to PTGX's edge.
  2. 2PCVX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3PTGX's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PTGX leads on balance
MetricPCVXPTGX
Revenue growth (YoY)0%28.5%
EPS growth (YoY)-1%34.4%
Gross margin0%99.7%
Operating margin0%58.6%
Return on equity (TTM)-11.9%20.3%
Debt to equity0.090.01

Performance

PTGX leads 4 of 6 windows
MetricPCVXPTGX
1 week (5 sessions)-0.8%-0.8%
1 month (20 sessions)-0.4%1.7%
3 months (63 sessions)5.2%-17.4%
6 months (126 sessions)21%28.2%
Year to date37.3%49.9%
1 year (252 sessions)37.5%54.3%

Technicals

PCVX has the stronger structure
MetricPCVXPTGX
RSI (14)49.538.9
ADX (14)26.619.7
Price vs 50-day1.8%-6.7%
Price vs 200-day9.8%9.8%
Volatility (1M, annualized)58.3%37.7%

Risk

PTGX is the more resilient
MetricPCVXPTGX
Beta1.260.91
Sharpe ratio0.791.24
Sortino ratio1.391.95
Max drawdown-28%-18.8%
Current drawdown-14.2%-17.4%
Annualized volatility56.2%40.1%
Value at risk (95%)-4.1%-3.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PCVX or PTGX?

On the Algovestiq AIQ Score, PTGX is the stronger of the two as of Nov 15, 2026, scoring 73 against PCVX's 66. The edge comes from quality and risk resilience. PCVX is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PCVX or PTGX the better buy right now?

PTGX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor PTGX over PCVX?

The composite weights Quality, Value, Momentum and Risk Resilience. PTGX leads Quality by 27 points; PTGX leads Risk Resilience by 17 points; PCVX leads Momentum by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, PCVX or PTGX?

Analyst price targets imply +93% upside for PCVX and +35% for PTGX, so the Street currently favors PCVX. That points the opposite way to the AIQ Score, which favors PTGX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PCVX or PTGX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PCVX or PTGX?

PTGX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PCVX or PTGX?

PCVX on the Momentum factor, by 11 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PCVX or PTGX?

PTGX is the more resilient of the two, so the other name carries the higher downside risk. PTGX on Risk Resilience, by 17 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PCVX more profitable than PTGX?

PTGX leads on the comparable margin measures — gross margin 0% vs 99.7%; operating margin 0% vs 58.6%; ttm roe -11.9% vs 20.3%.

Is PTGX's lead over PCVX getting stronger or weaker?

PTGX lead: Stable — the AIQ differential has held near 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-06-12, when PCVX moved ahead of PTGX.

What would change the PCVX vs PTGX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PCVX closes the Quality gap — currently 27 points behind, the largest single contributor to PTGX's edge; PCVX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; PTGX's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PCVX and PTGX?

PCVX: 5 bullish / 2 bearish / 1 neutral, conflicted. PTGX: 3 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PCVX is Golden Cross Active (bullish, long horizon). On PTGX it is Golden Cross Active (bullish, long horizon).

Compare PCVX and PTGX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.